« The Valley of the Media Dolls |
| With Google, your memories will last forever »
July 05, 2005
Pharmaceutical companies reconsider the future of blockbuster drugs
In the New York Times, Alex Berenson writes that blockbuster drugs are "so last century." Drug companies are starting to come to the realization that they do an "awful job of finding new medicines." Not only that -- "they rely too much on billion-dollar blockbuster drugs that are both overmarketed and overprescribed."
According to Big Pharma companies like Eli Lilly, the future is "not in blockbuster medicines like Prozac that are meant for tens of millions of patients, but rather in drugs that are aimed at smaller groups and can be developed more quickly and cheaply, possibly with fewer side effects." So will pharmaceutical companies based in New Jersey and New York, many of which have come to rely on the cash flows created by blockbuster drugs, also adapt their business models to the new reality?
+ TrackBacks (0) | Category: Biotech
- RELATED ENTRIES
- East Village bar up for sale on eBay
- Eliot Spitzer takes on the national cinema chains
- California winemakers to sell wine to New Yorkers via the Internet
- A blogger could become "Media Person of the Year"
- A la carte cable TV pricing
- NYSIA Incubator launch party tonight
- Why the mathematics of congestion pricing don't work
- Enjoy the holiday shopping bargains at Century 21 while you can